Gladman Dafna D, Helliwell Philip S, Mease Philip J
D.D. Gladman, MD, Division of Rheumatology, Department of Medicine, University of Toronto, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada;
P.S. Helliwell, MD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
J Rheumatol. 2024 Oct 1;51(Suppl 2):6-8. doi: 10.3899/jrheum.2024-0230.
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) started in August 2003 with 40 initial participants and celebrated its 20th anniversary with 1036 members, many of whom attended the annual meeting in Dublin, Ireland, on July 15 to 17, 2023. GRAPPA arose from a need experienced by psoriatic arthritis (PsA) and psoriasis (PsO) investigators to meet to address questions related to psoriatic disease (PsD). Though other groups were meeting at the time to classify and discuss PsA, GRAPPA arose from a desire to include international clinical and investigational researchers of both dermatology and rheumatology. The organization has built awareness of PsO and PsA, developed and validated research assessment tools to measure clinical status and disease outcomes, published multiple treatment recommendations, supported basic and clinical research on PsD pathophysiology, fostered interactions across research fields, and educated the future generation of PsO and PsA researchers. The group continues to focus on major priorities affecting patients with PsD and will continue evolving in the next decades.
银屑病和银屑病关节炎研究与评估小组（GRAPPA）于2003年8月成立，最初有40名参与者，在其成立20周年之际，已有1036名成员，其中许多人参加了2023年7月15日至17日在爱尔兰都柏林举行的年会。GRAPPA源于银屑病关节炎（PsA）和银屑病（PsO）研究人员的一种需求，即需要相聚一堂，解决与银屑病相关疾病（PsD）有关的问题。尽管当时其他小组也在开会对PsA进行分类和讨论，但GRAPPA的成立源于一种愿望，即纳入皮肤科和风湿病学领域的国际临床和研究人员。该组织提高了对PsO和PsA的认识，开发并验证了用于衡量临床状况和疾病结局的研究评估工具，发布了多项治疗建议，支持对PsD病理生理学的基础和临床研究，促进了跨研究领域的互动，并培养了下一代PsO和PsA研究人员。该小组继续专注于影响PsD患者的主要优先事项，并将在未来几十年继续发展。
